Anti-idiotypic antibodies reduce efficacy of the attenuated vaccine against highly pathogenic PRRSV challenge. - Wikidata - wikimedia - TriplyDB

Anti-idiotypic antibodies reduce efficacy of the attenuated vaccine against highly pathogenic PRRSV challenge.

Anti-idiotypic antibodies reduce efficacy of the attenuated vaccine against highly pathogenic PRRSV challenge.

http://www.wikidata.org/entity/Q35089195

about

Rescue and evaluation of a recombinant PRRSV expressing porcine Interleukin-4.Immune Control of PRRS: Lessons to be Learned and Possible Ways Forward.Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing properties.

P2860

Q36286076-30DE1FC8-5073-4085-8769-63E71A8BCDBF Q38668708-4C259B0A-AD73-4B43-9704-C36FB159A4AC Q41203252-7AFF5EDD-5CD2-4029-9B6B-2F25A5A6C385

P2860

Anti-idiotypic antibodies reduce efficacy of the attenuated vaccine against highly pathogenic PRRSV challenge.

http://www.wikidata.org/entity/Q35089195

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Anti-idiotypic antibodies redu ...... ly pathogenic PRRSV challenge.

@ast

Anti-idiotypic antibodies redu ...... ly pathogenic PRRSV challenge.

@en

type

label

Anti-idiotypic antibodies redu ...... ly pathogenic PRRSV challenge.

@ast

Anti-idiotypic antibodies redu ...... ly pathogenic PRRSV challenge.

@en

prefLabel

Anti-idiotypic antibodies redu ...... ly pathogenic PRRSV challenge.

@ast

Anti-idiotypic antibodies redu ...... ly pathogenic PRRSV challenge.

@en

P1433

Q35089195-7CBD10AD-331D-4EB1-AD4F-C7BFAE85572D

P1476

Q35089195-AA7E06F0-9B37-4D91-814A-DF13DD3ADB36

P2093

Q35089195-051E9E1E-2517-49E1-AEC1-F12407880638

Q35089195-38C171E8-5C3A-480E-B4BB-8E92DD653DE8

Q35089195-4DD870AF-2C8D-41D9-BF23-41CD87D693F6

Q35089195-4E06AF66-DC4D-4F4B-AA21-94A801076660

Q35089195-61B3E8FC-0881-481A-9E32-9C308719829B

Q35089195-8A908DB4-F19B-4902-BFFF-F7ADE9E60205

Q35089195-91B481B8-8D20-4977-A2A7-2BDAA0B10654

Q35089195-9F1F6206-8956-4484-8A4F-6567B780A793

Q35089195-A977618D-9CE3-4EC7-A209-15BAC7DDF97E

Q35089195-B68233E9-B538-4D12-A476-AD2FC948B544

P2860

Q35089195-0965DF64-1CB9-4E88-83FB-A92CC5CEB460

Q35089195-170B7E3F-8738-41ED-A4A2-D54984D3744C

Q35089195-1B66685E-79ED-437C-9FB7-ACC6DD1D7153

Q35089195-1C45507A-27B4-43DE-87F0-784FFFF98E93

Q35089195-20158760-1A4D-495F-B65C-E63BB5E75538

Q35089195-20ECDAF6-5DE2-462E-A857-9334FA411EE5

Q35089195-22983CF6-7E9A-434B-B786-AC5958F0C1DC

Q35089195-242F8276-0870-4E13-8E6A-74EACA2B4EFE

Q35089195-27760E47-20EE-493B-BE71-701C34801A44

Q35089195-30E36B02-54E9-4CAC-8380-1A7734809F17

P2888

Q35089195-ABECA310-F21E-4411-B562-C82DCFB2992A

P304

Q35089195-62972B95-5303-480B-9090-590D76C92FB6

P31

Q35089195-94005B57-A36A-4B10-BAA7-71A6A694C75E

P356

Q35089195-5E58689E-9371-4E90-B244-F2B850923ECA

P478

Q35089195-30C54E95-6FD5-4228-8DD1-1747838870BA

P50

Q35089195-D1883F1A-40C4-4088-8014-B22F1BFA9114

P577

Q35089195-7B367DB0-1A16-4B78-9F23-3CAF5AC581BA

P5875

Q35089195-BC6F9C82-266E-4326-ADF0-5C986C145A97

P6179

Q35089195-4589EBB6-3F5A-4C75-8831-9227563A57C7

P698

Q35089195-C5527FB3-6D98-496F-9B33-FDF4BFEF9E83

P921

Q35089195-B2AE3E82-51C1-49C3-8A64-44FB45A86364

P932

Q35089195-D2AB4F37-3BCA-4321-BD9F-962C638242BC

P356

1746-6148-10-39

P1433

BMC Veterinary Research

P1476

Anti-idiotypic antibodies redu ...... ly pathogenic PRRSV challenge.

@en

P2093

Chengbao Wang

http://www.w3.org/2001/XMLSchema#string

Chong Zhang

http://www.w3.org/2001/XMLSchema#string

En-Min Zhou

http://www.w3.org/2001/XMLSchema#string

Gaiping Zhang

http://www.w3.org/2001/XMLSchema#string

Gang Wang

http://www.w3.org/2001/XMLSchema#string

Ning Kong

http://www.w3.org/2001/XMLSchema#string

Qin Zhao

http://www.w3.org/2001/XMLSchema#string

Shuqi Xiao

http://www.w3.org/2001/XMLSchema#string

Xuehui Cai

http://www.w3.org/2001/XMLSchema#string

Yang Mu

http://www.w3.org/2001/XMLSchema#string

P2860

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

The interleukin-10 family of cytokines

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

Porcine FcγRIIb mediates enhancement of porcine reproductive and respiratory syndrome virus (PRRSV) infection.

Dynamic changes in inflammatory cytokines in pigs infected with highly pathogenic porcine reproductive and respiratory syndrome virus.

The level of virus-specific T-cell and macrophage recruitment in porcine reproductive and respiratory syndrome virus infection in pigs is independent of virus load.

Towards a network theory of the immune system.

Comparison of molecular and biological characteristics of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (ingelvac PRRS MLV), the parent strain of the vaccine (ATCC VR2332), ATCC VR2385, and two recent field isol

Infection with Porcine reproductive and respiratory syndrome virus stimulates an early gamma interferon response in the serum of pigs

The assessment of efficacy of porcine reproductive respiratory syndrome virus inactivated vaccine based on the viral quantity and inactivation methods.

P2888

1746-6148-10-39

P304

39

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1746-6148-10-39

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260129347

http://www.w3.org/2001/XMLSchema#string

P6179

1009274763

http://www.w3.org/2001/XMLSchema#string

P698

24507659

http://www.w3.org/2001/XMLSchema#string

P921

attenuated vaccine

P932

3921987

http://www.w3.org/2001/XMLSchema#string